New research has revealed how a probiotic bacterium
used to treat irritable bowel syndrome can soothe gut bacterial
infections caused by Salmonella.
Probiotics
are types of 'good' or 'benefical' bacteria. As well as aiding the
immune system and digestion, scientists thunk that mixtures of pro
biotic bacteria can help to reduce the growth of certain types of
bacteria. Due to this, scientists are looking at the right types of
probiotic bacteria.
Specifically, microbiologists have been studying a probiotic strain of Escherichia coli (not all strains of E. coli are harmful). A research group have found that a type of E. coli (called Nissle 1917 or Mutaflor) reduces Salmonella
colonization by competing with the pathogen for iron, an essential
nutrient that salmonella acquires in the gut in order to replicate at
high levels.
Types of Salmonella
bacteria can potentially cause illnesses such as typhoid fever,
paratyphoid fever, and other food borne illness. Most persons infected
with Salmonella develop diarrhea, fever, and abdominal cramps 12 to 72
hours after infection.
For many decades E. coli Nissle 1917
strain has been administered to patients with a variety of bowel
disorders (such as ulcerative colitis and Crohn’s disease). It now
appears that this beneficvial bacterium could be used to treat other
types of disease.
The study was conducted by UC Irvine microbiologists and the findings have been published in the journal Cell Host & Microbe, in a paper titled "Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron."
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources